Unknown

Dataset Information

0

Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice.


ABSTRACT: BACKGROUND & AIMS:Acetaminophen (APAP)-induced liver injury is the most frequent cause of acute liver failure in the US and many other countries. Metabolism of APAP results in formation of APAP protein adducts (APAP-AD) in hepatocytes and triggers mitochondrial dysfunction and necrosis. However, the mechanisms for how APAP-AD are removed from hepatocytes remain unknown. METHODS:Mice or primary hepatocytes were treated with APAP. APAP-AD were determined by immunoblot, immunostaining and high pressure liquid chomatography with electrochemical detection analysis. RESULTS:We found that APAP-AD were detected at 1h, peaked at approximately 2h, declined at 6h and almost full removed at 24h post treatment with APAP in mouse livers and in primary mouse hepatocytes. APAP-AD displayed a punctate pattern and were colocalized with GFP-LC3 positive autophagosomes and Lamp1 positive lysosomes in APAP-treated primary hepatocytes. Moreover, isolated autophagosomes and autolysosomes from APAP-treated mouse livers contained APAP-AD, suggesting autophagy may selectively remove APAP-AD. APAP-AD were detected in both detergent soluble and insoluble pools in APAP-treated mouse livers and hepatocytes. More importantly, pharmacological inhibition of autophagy by leupeptin or chloroquine increased whereas induction of autophagy by Torin 1 decreased serum APAP-AD levels in APAP-treated mice, which correlated with alanine aminotransferase levels and liver necrosis. Furthermore, SQSTM1/p62, an autophagy receptor protein, was recruited to APAP-AD. Adenovirus-mediated shRNA knockdown of SQSTM1/p62 led to increased APAP-AD and necrosis in primary hepatocytes. CONCLUSIONS:Our data indicate that APAP-AD are removed though selective autophagy. Pharmacological induction of autophagy may be a novel promising approach for treating APAP-induced liver injury. LAY SUMMARY:Acetaminophen overdose can form acetaminophen protein adducts and mitochondria damage in hepatocytes resulting in liver injury. Activation of autophagy-lysosomal degradation pathway can help to remove acetaminophen protein adducts. Pharmacological induction of autophagy may be a novel promising approach for treating APAP-induced liver injury.

SUBMITTER: Ni HM 

PROVIDER: S-EPMC4955750 | biostudies-literature | 2016 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications

Removal of acetaminophen protein adducts by autophagy protects against acetaminophen-induced liver injury in mice.

Ni Hong-Min HM   McGill Mitchell R MR   Chao Xiaojuan X   Du Kuo K   Williams Jessica A JA   Xie Yuchao Y   Jaeschke Hartmut H   Ding Wen-Xing WX  

Journal of hepatology 20160502 2


<h4>Background & aims</h4>Acetaminophen (APAP)-induced liver injury is the most frequent cause of acute liver failure in the US and many other countries. Metabolism of APAP results in formation of APAP protein adducts (APAP-AD) in hepatocytes and triggers mitochondrial dysfunction and necrosis. However, the mechanisms for how APAP-AD are removed from hepatocytes remain unknown.<h4>Methods</h4>Mice or primary hepatocytes were treated with APAP. APAP-AD were determined by immunoblot, immunostainin  ...[more]

Similar Datasets

| S-EPMC2908515 | biostudies-literature
| S-EPMC10136285 | biostudies-literature
| S-EPMC9739375 | biostudies-literature
| S-EPMC9137993 | biostudies-literature
| S-EPMC7827407 | biostudies-literature
| S-EPMC6759817 | biostudies-literature
| S-EPMC8935220 | biostudies-literature
| S-EPMC10902631 | biostudies-literature
| S-EPMC3245329 | biostudies-literature
| S-EPMC4444402 | biostudies-literature